Exciva
- Health & Biotech
- Heidelberg, DE
- Founded 2016
- Private
- exciva.com
German biotech founded in 2016 in Heidelberg that closed a EUR 51M Series B in January 2026.
$59MEquity raised in 2025–20262025 — · 2026 $59M · 1 equity round
$59MEquity raised, all time1 equity round sourced so far
—Latest valuationnot disclosed
Rounds over time log-scaled amounts
Funding history 1 round · 1 source
Earlier rounds not yet sourced. Exciva was founded in 2016 and raised before 20 Jan 2026; only the rounds below are sourced so far, so its all-time equity total understates its history.
- Series BAmount$59MEUR 51MPost-money—✓ Confirmed
- Earlier rounds not yet sourced
Investors 8
- EQT Life Sciences1
- Gimv1
- Andera Partners
- Carma Fund
- Fountain Healthcare Partners
- LBBW
- LifeArc Ventures
- Modi Ventures
Highlighted investors led at least one equity round; the number is equity rounds taken part in.
Related companies shared investors
Figures in USD at the time of each round. See the methodology for how rounds are sourced and verified. Exciva and its logo are trademarks of their owners, used here for identification only.
